Latest Headlines

Latest Headlines

India intends to establish drug testing labs in effort to boost quality

India is planning to spend about INR17.5 billion ($270 million) to make sure every state has a drug testing laboratory as part of an effort to improve manufacturing quality.

Pfizer adding jobs to Ireland plant that had been slated to close

Pfizer announced plans to sell a plant in India that was slated to be shuttered. But another Pfizer facility in Ireland that was once on the chopping block has not only been taken off the list of facilities no longer needed but is adding several dozen jobs.

India considers drug testing labs in each state

India may house drug testing laboratories in each state under an INR17.5 billion ($270 million) plan to shore up quality.

Something's got to give in India's pharma policy contradictions

India wants to cap drug prices at home while ramping up sales of generics to Western markets targeting the U.S.--all while dozens of manufacturing plants are under regulatory scanners on quality and testing.

Abbott said to expand manufacturing, other operations in India

Abbott Laboratories wlll expand its manufacturing, as well as other operations, in India, though a dollar amount was not given by the pharmaceutical giant.

MSF campaigns at UN summit meeting to ease pressure on India's drug IP policies

Médecins Sans Frontières warned in a high-profile campaign during the United Nations summit on development in in New York that the United States is pressuring Indian Prime Minister Narendra Modi to change the country's intellectual property policies for drugs, which could result in millions of people around the world being unable to access medicines.

India's Dr. Reddy's strategy on biosimilars now refined for big punches

A rope-a-dope strategy of sorts on biosimilars is in play for India's Dr. Reddy's as it shifts from a strategy of racing to the domestic market with products in favor of a coiled approach that will let it strike out in several markets in a burst.

Sun Pharmaceutical's Shanghvi drops from top spot in Forbes India rich list

Sun Pharmaceutical founder Dilip Shanghvi has dropped from the pinnacle on the  Forbes India  Rich List to the second spot, but plenty of pharmaceutical-related business leaders remain in the top tier.

Manufacturers' association says pharma contract manufacturing in India growing at 20%

The Indian Drug Manufacturers' Association says the country's pharmaceutical contract manufacturing industry is growing at 20%.

Apotex recalls cevimeline hydrochloride drugs made in India as FDA notes stability issues

Within weeks of getting a conditional nod to resume shipments from two of the company's manufacturing units in India, Canada's largest generics maker has recalled 117,644 bottles of cevimeline hydrochloride capsules in the U.S. that were made by the company's Indian arm, Apotex Research, the Business Standard newspaper reports.